CONNECT, PARTNER & INNOVATE WITH

THE BIOREGIONOF CATALONIAAT BIO 2012

June 18-21, 2012 Booth 437

Boston Convention & Exhibition Center 415 Summer Street • Boston (USA)

More information at:

www.biocat.cat/bio2012

With the support of:

BIOCAT, LEADING BIOTECHNOLOGY IN CATALONIABOOTH 437Biocat is the entity that coordinatesand promotes innovation in biotechnology, biomedicine and medical technology sector in Catalonia, following a strategic plan focused on:

• Consolidating Catalonia's biocluster• Promoting Business competitiveness• Fostering Internationalisation• Training and attracting talent• Generating a positive social perception of biotechnology

20 SCIENCE ANDTECHNOLOGYPARKS

481COMPANIES

10UNIVERSITIES(out of 12) offeringstudies in life sciencesand two of the 20top-ranked businessschools in the world

433RESEARCHGROUPS workingin life sciences

80RESEARCHCENTERSin life sciences

74(European ResearchCouncil) GRANTSawarded to Catalanscientists workingin life sciences,between 2007and 2011

13HOSPITALSwith noteworthyresearch activity(out of 214) and5 research institutesrecognized bythe Spanishgovernment

(71 pharmaceutical, 91 biotechnology, 106 innovative medical technology, 29 fine chemicals, 45 food, 9 bioinformatics and the rest provide support services or are linked to the sector in some way)

Source: Biocat Report 2011 and web Directory

ERC

BIOREGIONOF CATALONIA PAVILION

VISIT OUR PAVILION AND MEET THE KEY PLAYERS OF THE CATALAN BIOTECHNOLOGY AT BIO:

72 COMPANIES ANDSCIENTIFIC INSTITUTIONS MORE THAN 100 DELEGATES

MORE THAN 60% OF THESPANISH REPRESENTATION

FLOORPLAN FOR 2012 BIO

ENTRANCE ENTRANCE

BUSINESS FORUM

PARTNERINGDESK

BOOTH 437M

ASSA

CHUS

ETTS

ONTA

RIO

QUEB

EC

CAN

ADA

BIOMARYLAND

GERMANY ITALY

SPAINPAVILION

PEN

NSY

LVAN

IABI

O

ENTR

ANCE

BIOBASQUE

SPAIN

CATALONIA

ANDALUCIABIOREGION

FRAN

CE

GEORGIA

ENTR

ANCE

437-31 AB-BIOTICS437-47 AB-THERAPEUTICS437-42 ALTHIA437-38 ANAXOMICS437-33 AROMICS437-45 ARCHIVEL437-37 BCN PEPTIDES437-34 BIOCHEMIZE437-28 BIONURE 437-23 GP PHARM437-51 GRIFOLS ENGINEERING437-54 HEXASCREEN CULTURE TECHNOLOGIES437-41 IMMUNNOVATIVE DEVELOPMENTS437-50 INTELLIGENT PHARMA437-52 JANUS DEVELOPMENTS437-36 KYMOS

437-29 LABORATORIOS RUBIÓ437-48 LIFE SCIENCE ENTREPRENEURS437-44 LYKERA BIOMED437-35 NANOTARGETING437-40 NEUROTEC PHARMA437-30 OMNIA MOLECULAR437-39 ORYZON GENOMICS437-24 PALAU PHARMA437-49 PALOBIOFARMA437-25 PLASMIA BIOTECH437-32 READYCELL437-43 RECERCA CLÍNICA437-46 REIG JOFRÉ GROUP437-26 SALVAT437-53 TRIFERMED437-27 VCN BIOSCIENCIES

COMPANIES

• ADVANCELL • BAKER & MCKENZIE• BIOEMPRÈN• BIOIBÉRICA• BIOKIT• CAIXA CAPITAL RISC

• ACC1Ó• BLOOD AND TISSUE BANK (BST)• BARCELONA CITY COUNCIL• BARCELONA SCIENCE PARK• BIOCAT• BIOMEDICAL ENGINEERING RESEARCH CENTRE (CREB-UPC)• BIONANOMED CATALUNYA NETWORK• BOSCH I GIMPERA FOUNDATION• CATALAN INSTITUTE OF NANOTECHNOLOGY (ICN) • CENTRE FOR GENOMIC REGULATION (CRG) • CLÍNIC FOUNDATION FOR BIOMEDICAL RESEARCH • GUTTMANN UNIVERSITARY INSTITUTE FOR NEUROREHABILITATION

• IMB-CNM NATIONAL MICROELECTRONICS CENTER (CSIC)• INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA (IQAC-CSIC)• IRB BARCELONA• LEITAT TECHNOLOGY CENTER• ONCOCAT NETWORK• PARC DE L'ALBA, ALBA SYNCHOTRON• POMPEU FABRA UNIVERSITY (UPF) • RESEARCH & TECHNOLOGY INSTITUTE FOR FOOD & AGRICULTURE (IRTA)• SECOT• UNIVERSITAT POLITÈCNICA DE CATALUNYA (UPC)• UNIVERSITAT POMPEU FABRA (UPF)

COMPANIES

INSTITUTIONS

BOOTH DISTRIBUTION

BIOCAT’S BOOTH

• DRACONIS PHARMA• ERA BIOTECH • ESTEVE• GESAWORLD • GRI-CEL• LACER

• NATURA BISSÉ INTERNATIONAL• PERFORMLAB • ROUSAUD COSTAS DURAN• SAGETIS BIOTECH• THROMBOTARGETS • YSIOS CAPITAL PARTNERS

AB-BIOTICS

Contact: Miquel A. Bonacherainfo@ab-biotics.com www.ab-biotics.com

AB-THERAPEUTICS

Contact: Carles Domènech carles.domenech@ab-therapeutics.com www.ab-therapeutics.com

ANAXOMICS

Contact: Vesna Radovanovicvesna@anaxomics.com www.anaxomics.com

AROMICS

Contact: Carmen Plasencia info@aromics.eswww.aromics.es

ARCHIVEL

Contact: Olga Rué orue@archivelfarma.com www.archivelfarma.com

BIONURE

Contact: Albert Zamorainfo@bionure.comwww.bionure.com

DRACONIS PHARMA

Contact: Lluis Gomezlgomez@draconispharma.comwww.draconispharma.com

ERA BIOTECH

Contact: Miriam Bastidainfo@erabiotech.comwww.erabiotech.com

ESTEVE

Contact: Mark Mayhewmmayhew@esteve.eswww.esteve.es

GP PHARM

Contact: Sandra Sánchezsasanchez@gp-pharm.com www.gp-pharm.com

BCN PEPTIDES

Contact: Jordi Pirójpiro@bcnpeptides.com www.bcnpeptides.com

BAKER&MCKENZIE

Contact: Montserrat LlopartMontserrat.Llopart@bakermckenzie.comwww.bakermckenzie.com

ALTHIA

Contact: Anna Colomerinfo@althia.eswww.althia.es

BIOIBÉRICA

Contact: Josep Vergésverges@bioiberica.comwww.bioiberica.com

BIOCHEMIZE

Contact: Jaume Mirjmir@biochemize.comwww.biochemize.com

BIOEMPRÈN

Contact: Jaume Amatjamat@bioempren.comwww.bioempren.com

CCOMPANIES

437-31 437-47 437-42

ADVANCELL

Contact: Clara Campàs de Moyaadvancell@advancell.netwww.advancell.net

437-38 437-45 437-33

437-37 437-34

437-28

437-23

437

437

437 437

CAIXA CAPITAL RISK

Contact: Patricia Buréspbures@caixacapitalrisc.eswww.caixacapitalrisc.es

437

BIOKIT

Contact: Pau Bruguerapbruguera@biokit.comwww.biokit.com

437 437

437 437

GESAWORLD

Contact: José María Pérezjperez@gesaworld.comwww.gesaworld.com

437

HEXASCREEN CULTURETECHNOLOGIES

Contact: Javier Amayra jamayra@hexascreen.com www.hexascreen.com

IMMUNOVATIVE DEVELOPMENTS

Contact: Natalia de la Figuera n�guera@immunnovative.comwww.immunovative.com

INTELLIGENT PHARMA

Contact: Ismael Tejeroitejero@intelligentpharma.comwww.intelligentpharma.com

KYMOS

Contact: Joan Puig de Doujpuig@kymos.es www.kymos.es

LABORATORIOS RUBIÓ

Contact: Ingrid Chasan ichasan@laboratoriosrubio.com www.laboratoriosrubio.com

LACER

Contact: Xavier Berthetxavier.berthet@lacer.eswww.lacer.es

GRI-CEL

Contact: Dirk Buscherdirk.buscher@grifols.comwww.grifols.com

LYKERA BIOMED

Contact: Francesc Mitjans fmitjans@lykerabiomed.com www.lykerabiomed.com

GRIFOLS ENGINEERING

Contact: Oriol Argemí info.ge@grifols.comwww.grifolsengineering.com

LIFE SCIENCE ENTREPRENEURS

Contact: François Arcandarcandf@LifSciE.comwww.LifSciE.com

JANUS DEVELOPMENTS

Contact: Marion Chalumeau mchalumeau@janusdevelopments.com www.janusdevelopments.com

NEUROTEC PHARMA

Contact: Marco Pugliese marcopugliese@neurotec-pharma.comwww.neurotec-pharma.com

NANOTARGETING

Contact: Aurora Conill aconill@nanotargeting.euwww.nanotargeting.eu

437-51 437-54 437-41

437-50 437-52 437-36 437-29

437-48 437-44 437-35

437-40

NATURA BISSE INTERNATIONAL

Contact: Joaquin Serra joaquinserra@naturabisse.comwww.naturabisse.es

437

437

437

CCOMPANIES

ORYZON GENOMICS

Contact: Emili Torrell etorrell@oryzon.comwww.oryzon.com

437-39

OMNIA MOLECULAR

Contact: Ralph Klingmann landreu@omniamol.com www.omniamol.com

437-30

PROFILE OF DELEGATES

AB-BIOTIC

SAB-TH

ERAPEU

TICS

ADVANCELL

ALTHIA

ANAXOMICSAROMICS

ARCHIVELBAKER

&McKEN

ZIE

BCN PEPTID

ES

BIOCHEMIZE

BIOIBÉRICA

BIOEMPRÈN

BIOKITBIONURE CAIXA CAPITA

L RISK

DRACONIS PHARMA

ERA BIOTE

CHES

TEVE

GESAW

ORLDGP-PHARM GRI-C

ELGRIFO

LS EN

GINEE

RING

HEXASCREE

N CULTURE T

ECHNOLO

GIES

IMMUNOVATIV

E DEV

ELOPMEN

TS

INTE

LLIGEN

T PHARMA

JANUS DEV

ELOPMEN

TS

KYMOS LA

BORATORIOS RUBIÓ

SALVAT

LACER

LIFE S

CIENCE E

NTREP

RENEU

RS

LIKER

A BIOMED

NANOTARGET

ING

NATURA BISSE I

NTERNATIO

NAL

NEUROTE

C PHARMA

OMNIA MOLE

CULAR

ORYZON GEN

OMICS

PALAU PHARMA

PALOBIOFA

RMA

PERFORMLA

B

PLASMIA

BIOTECH

READYCEL

LREIG

JOFR

É GROUP

ROUSAUD COSTAS DURAN

SAGETIS BIOTE

CHTH

ROMBOTARGET

S

TRIFE

RMEDVCN BIOSCIEN

CES

YSIOS

01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46

HUMAN HEALTH (DIAGNOSTIC - VACCINATIONS)

HUMAN HEALTH (THERAPEUTIC)

AGROFOOD (AGRICULTURE, LIVESTOCK FARMING, FOOD & FORESTRY)

ANIMAL HEALTH

COSMETICS

BIOPROCESSES, BIOFUELS, BIOMATERIALS

AUXILIARY SERVICES

ENVIRONEMENT

LABORATORY EQUIPMENT

BIOCATALYSIS

ACTIVE PHARMACEUTICAL INGREDIENTS

COMPUTATIONAL SERVICES

CONSULTANCY*

* (1) BUSINESS DEVELOPMENT (2) BIOPHARMACEUTICS ENGINEERING (3) TECHNOLOGY TRANSFER (4) PUBLIC HEALTH & HEALTH MANAGEMENT

LAW FIRM

VENTURE CAPITAL

DEVE

LOPM

ENT

PIPE

LIN

EAC

TIVI

TY

BASIC RESEARCH

PRECLINICAL (IN VITRO TRIAL)

PRECLINICAL (IN VIVO TRIAL)

CLINICAL PHASE I, II, & III

CLINICAL PHASE IV (IN MARKET)

PROD

UCT

STAT

UTS BASIC RESEARCH

PILOT PRODUCT

VALIDATION TRIALS

REQUEST FOR AUTHORISATION

IN MARKET

1 14 2 3

47 48 49 50

RECER

CA CLINICA

Some of the companies may fall into more than one category

COMPANIES' PROFILE

Apart from Biocat, there are other institutional representatives coming from universities, science & technology parks, research & technology centers, support entities, networks and public administration.

0%

43%

53%

57%

32%

17%

10% 20% 30% 40% 50% 60% 70%

BASIC RESEARCH

PRECLINICAL (IN VITRO TRIAL)

PRECLINICAL (IN VIVO TRIAL)

CLINICAL PHASE I, II, & III

CLINICAL PHASE IV (IN MARKET)

DEVELOPMENT PIPELINE

0% 5% 10% 15%

15%

17%

21%

6%

11%

20% 25%

BASIC RESEARCH

PILOT PRODUCT

VALIDATION TRIALS

REQUEST FOR AUTHORISATION

IN MARKET

PRODUCT STATUS

ACTIVITY

36,2%

72,3%

4,3%

0%

10%

20%

30%

40%

50%

60%

70%

80%

17%10,6% 8,5% 6,4%

10,6%12,8%

HUM

AN H

EALT

H(D

IAGN

OSTI

C-VA

CCIN

ATIO

NS)

HUM

AN H

EALT

H(T

HERA

PEUT

ICS)

AGRO

FOOD

ANIM

AL H

EALT

H

BIOP

ROCE

SSES

,BI

OFUE

LS, B

IOM

ATER

IALS

AUXI

LIAR

Y SE

RVIC

ES

OTHE

R

CON

SULT

ANCY

LAW

FIR

M/

VEN

TURE

CA

PITA

L

RECERCA CLINICA

Contact: Lluís Canocano.l@recercaclinica.comwww.recercaclinica.com

YSIOS CAPITAL PARTNERS

Contact: Raúl Martinysios@ysioscapital.comwww.ysioscapital.com

TRIFERMED

Contact: Stephanie Reidsreid@trifermed.comwww.trifermed.com

VCN BIOSCIENCIES

Contact: Manel Cascalló mcascallo@vcnbiosciences.com www.vcnbiosciences.com

SAGETIS BIOTECH

Contact: Eduard Diviuediviu@sagetis-biotech.comwww.sagetis-biotech.com

PALAU PHARMA

Contact: Ignacio Faus ifaus@palaupharma.com www.palaupharma.com

PALOBIOFARMA

Contact: Julio Castro Palominojcastro@palobiofarma.com www.palobiofarma.com

REIG JOFRÉ GROUP

Contact: Ignacio Vila ignacio.vila@reigjofre.comwww.reigjofre.com

ROUSAUD COSTAS DURAN

Contact: Ignasi Costas rcd@rcdslp.comwww.rcdslp.com

READYCELL

Contact: Josep O. Nicolásjonicolas@readycell.comwww.readycell.com

PLASMIA BIOTECH

Contact: Esteve Guardiaesteve@plasmiabiotech.comwww.plasmiabiotech.com

PERFORMALB

Contact: Marc Ramisramism@upv.eswww.performlab.es

SALVAT

Contact: Cristina Viaynacviayna@salvatbiotech.com www.salvatbiotech.com

437-24

437

437-49 437-25

437-32 437-46

437-43 437-26 437-53

437-27

THROMBOTARGETS

Contact: Ignasi Miquelignasimiquel@thrombotargets.comwww.thrombotargets.com

437

437 437

437

CCOMPANIES

INSTITUTE OFADVANCEDCHEMISTRYOF CATALONIA(IQAC-CSIC)

Contact: Isabel Masip isabel.masip@iqac.csic.eswww.iqac.csic.es

BIOMEMS GROUPBIOSYSTEMS BIOENGINEERING(IMB-CNM, CSIC)

Contact: Francesc Xavier Muñozfrancescxavier.munoz@imb-cnm.csic.eswww.imb-cnm.csic.es

CLÍNIC FOUNDATIONFOR BIOMEDICALRESEARCH

Contact: Yolanda Lizarragaylizarra@clinic.ub.eswww.fundacioclinic.org

BIOCATContact: Adela Farré afarre@biocat.catwww.biocat.cat

BOSCH I GIMPERAFOUNDATION

Contact: Inma Íñigueziiniguez@fbg.ub.eswww.fbg.ub.edu

BIOMEDICALENGINEERINGRESEARCH CENTRE(CREB-UPC)

Contact: Manel Gonzálezmanel.gonzalez@upc.eduwww.creb.upc.es

UNIVERSITATPOLITÈCNICADE CATALUNYA (UPC)

Contact: Oscar Carbooscar.carbo@upc.eduwww.upc.edu

LEITATTECHNOLOGICALCENTER

Contact: Francesc Mitjans biomed@leitat.org www.leitat.org

BARCELONACITY COUNCIL

Contact: Jordi Sacristan jordi.sacristan@barcelonactiva.cat www.bcn.cat/barcelonabusiness

ACC1Ó

Contact: Clara Barrenechecbarreneche@catalonia.com www.acc10.com

BANC DE SANGI TEIXITS (BST)

Contact: Aurora Masip amasip@bst.cat www.bst.cat

UNIVERSITATPOMPEUFABRA (UPF)

Contact: Melquiades Calzado melquiades.calzado@upf.eduwww.upf.edu

CENTRE FORGENOMICREGULATION (CRG)

Contact: Xavier Rubies xavier.rubies@crg.euwww.crg.eu

BIONANOMEDCATALUNYA NETWORK

Contact: Carlos Lurigadosinfo@bionanomedcat.org www.bionanomedcat.org

IRB BARCELONA

Contact: Cristina Horcajada cristina.horcajada@irbbarcelona.orgwww.irbbarcelona.org

RESEARCH &TECHNOLOGYINSTITUTE FOR FOOD& AGRICULTURE (IRTA)

Contact: Eliecer Lopez eliecer.lopez@irta.eswww.irta.es

GUTTMANNUNIVERSITARYINSTITUTE FORNEUROREHABILITATION

Contact: Josep M Tormosjmtormos@guttmann.comwww.guttmann.com

BARCELONASCIENCE PARK

Contact: Jesús Purroy jpurroy@pcb.ub.catwww.apcb.ub.cat

437 437 437 437 437

437

437 437 437 437 437

437 437 437 437 437

437 437 437

CATALANINSTITUTEOF NANOTECHNOLOGY(ICN)

Contact: Jordi Reverterjordi.reverter@icn.catwww.icn.cat

PARC DE L'ALBA,ALBA SYNCHOTRON

Contact: Guy Molénatguy.molenat@gmail.comwww.cells.es

437

ONCOCAT NETWORK

Contact: Carlos Lurigadosinfo@oncocat.orgwww.oncocat.org

437

IINSTITUTIONS

AGENDA

EVERY DAY:COMPANY

PRESENTATIONS

Ask us for thecomplete schedule!

7:30amCATALONIA RACE 5 KM.

Meeting point: Nine Zero Hotel Network in casual & healthy environment!

2:00pm – 2:45pmBREAKOUT SESSION

Room: 254A Crossing Borders and Boundaries – Emerging Strategies

to Promote International CollaborationCome learn new approaches from 4 leading

biotech regions: Massachusetts, North Carolina,Israel and Catalonia

3:30pm – 4:30pmCLUSTER HOUR: MEET EUROPE’S CLUSTERS

AND THEIR GLOBAL PARTNERSBioRegion of Catalonia presentation. Organiser: CEBR

Booth 3165 – European Commission

6:30pm – 7:30pmPRESENTATION OF CATALONIA INTERNATIONAL

LIFE SCIENCE REPORT – ERNST & YOUNG

7.30pm – 9.30pm CATALAN NETWORKING EVENT

Boston Common Hotel & Conference Center40 Trinity Place. Boston, MA 02116

TUESDAY,JUNE 19TH

SUNDAY,JUNE 17TH

1:00pm – 6:30pm

JUNE 20TH 3:00pm - ORYZON

International Cancer ClusterShowcase (satellite event)

Whitehead Institute.Nine Cambridge Center,Cambridge, MA 02142

INNOVATIVE ONCOLOGYPIPELINES PRESENTATION BY:

AB THERAPEUTICSONCOCAT NETWORKORYZON GENOMICS WEDNESDAY,

JUNE 20TH

Patriots Room - 104B

MORE INFOi

MORE INFOi

MORE INFOi

MORE INFOi

MORE INFOi

MORE INFOi

MORE INFOi

Venue: Boston Common Hotel - 40 Trinity Place, Boston, MA

WEDNESDAY, JUNE 20TH, 2012 7.30 pm - 9.30 pm

The event will count on the presence of R. Hon. Mr. Artur Mas,President of the Catalan Government

A Mediterranean cocktail and Catalan drinkswill be served during the network event

R.S.V.P.: events@biocat.cat

Organized by: Golden Sponsor:

BOOTH 437

THE CATALAN DELEGATION INVITES YOU TO OUR

BIO 2012 RECEPTION

Anunci BESMARCH 11–13, 2013BARCELONA, SPAIN

www.ebdgroup.com/bes

WHERE THE GLOBAL BIOTECH INDUSTRY COMES TO PARTNER

7th Annual International Partnering Conference

Producer Supported by Regional Host Sponsors

Save the date and join us in Barcelona!

Why Barcelona?

Because it is the ideal location for your biobusiness.

Barcelona City Council and Biocat are proud to introduce you the “biocapital” of Southern Europe. With more than 480 companies, 430research groups on life sciences, 20science & technology parks, 10universities and 13 top level hospitals, Catalonia is the most dynamic bioregion in the Euro-Mediterranean area and its capital, Barcelona, the main biotechnology hub.

CONNECT, PARTNER & INNOVATE WITH

THE BIOREGIONOF CATALONIAAT BIO 2012

June 18-21, 2012 Booth 437

Boston Convention & Exhibition Center 415 Summer Street • Boston (USA)

More information at:

www.biocat.cat/bio2012

With the support of: